Notes / Company

Indoco Remedies Ltd.

INDOCO BSE 532612 ISIN INE873D01024 Pharmaceuticals

Fundamentals

Market cap: ₹1,883 cr
ROE: 0.00%
Debt / equity: 0.96
Div yield: 0.10%
52-week range: 162.19 — 349.80

The timeline — 1 note on Indoco Remedies Ltd.

May 2026

28 May 26 · 5:57 PM IST Lead

Lead · Small cap

Indoco Remedies lands German health approval for Baddi plant

The German Health Authority cleared Indoco's Baddi Plant III for oral solid dosage production, opening a new route into EU markets.

Verify on exchange BSE filings for INDOCO NSE filings for INDOCO